Barriers to antiretroviral medication adherence in HIV-infected women

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 12, Issue 4, 2000, Pages 377-386

  Johnston Roberts, Kathleen ^a   Mann, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DRUG THERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL INTERACTION; SWEATING; VOMITING;

EID: 0033867624     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120050123774     Document Type: Article

References (20)

1. ALTICE, F. & FRIEDLAND, G.H. (1998). The era of adherence in HIV therapy. Annals of Internal Medicine, 6, 503-505.
2. CHESNEY, M. (1997). New antiretroviral therapies: adherence challenges and strategies. Presented at the Adherence in HIV Therapy: Implications for Nursing Practice Conference, San Francisco, 3 June.
3. COLLIER, A.C., COOMBS, R.W., SCHOENFIELD, D.A., BASSETT, R.L., TIMPONE, J., BARUCH, A., JONES, M., FACEY, K., WHITACRE, C., MCAULIFFE, V.J., FRIEDMAN, H.M., MERIGAN, T.C., REICHMAN, R.C., HOOPER, C. & COREY, L. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. New England Journal of Medicine, 334, 1011-1017.
4. CU-UVIN, S., FLANIGAN, T.P., RICH, J.D., MILENO, M.D., MAYER, K.H. & CARPENTER, C.C.J. (1996). Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women. American Journal of Medicine, 101, 316-322.
5. DIMATTEO, M.R. & DINICOLA, D. (1982). Achieving patient compliance: the psychology of the medical practitioner's role. New York: Pergamon Press.
6. ELDRED, L.J., WU, A.W., CHAISSON, R.E. & MOORE, R.D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18, 117-125.
7. FREEMAN, R.C., RODRIGUEZ, G. & FRENCH, J.F. (1996). Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue. AIDS Education and Prevention, 8, 58-71.
8. HAYNES, R.B., TAYLOR, D.W. & SACKETT, D.L. (1979). Compliance in health care. Baltimore: Johns Hopkins University Press.
9. HECHT, F.M., GRANT, R.M., PETROPOULOS, C.J., DILLON, B., CHESNEY, M.A., TIAN, H., HELLMANN, N.S., BANDRAPALLI, N.I., DIGILIO, L., BRANSON, B. & KAHN, J.O. (1998). Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. New England Journal of Medicine, 339, 307-311.
10. ICKOVICS, J. & RODIN, J. (1992). Women and AIDS in the United States: epidemiology, natural history, and mediating mechanisms. Health Psychology, II, 1-16.
11. LEY, P. (1988). Communicating with patients: improving satisfaction and compliance. London: Croom Helm.
12. MANN, T. (in press). Effects of future writing and optimism on health behaviors in HIV-infected females.
13. MUMA, R.D., Ross, M.W., PARCEL, G.S. & POLLARD, R.B. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7, 439-447.
14. O'BRIEN, M.K., PETRIE, K. & RAEBURN, J. (1992). Adherence to medication regimens: updating a complex medical issue. Medical Care Review, 49, 435-454.
15. PROJECT INFORM (1997). The science and marketing of simpler dosing (November, pp. 6-7). Project Inform Perspective.
16. SAN FRANCISCO AIDS FOUNDATION (1996). Overview of HIV protease inhibitors and new HIV treatment strategies. Bulletin of Experimental Treatments for AIDS, July.
17. STRAUSS, A. & CORBIN, J. (1990). Basics of qualitative research: grounded theory procedures and techniques. Newbury Park: Sage.
18. UNGVARSKI, P.J. (1997). Update on HIV Infection. American Journal of Nursing, 97, 44-52.
19. UNITED STATES FOOD AND DRUG ADMINISTRATION (1999). Antiretroviral HIV drug approvals and pediatric labeling information [http://www.fda.gov/oashi/aids/pedlbl. html], 21 January.
20. VOLBERDING, P. (1996). New treatment options and their implications for behavioral research. Presented at the Winter Lecture Series at the Center for AIDS